ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for ClearPoint Neuro
ClearPoint Neuro has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?